0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

news@JAMA | 
JAMA. 2014;311(13):1281. doi:10.1001/jama.2014.2920.

Clinical Trials Update | 
Anita Slomski
JAMA. 2014;311(8):790. doi:10.1001/jama.2014.1553.

Health Agencies Update | 
Bridget M. Kuehn, MSJ
JAMA. 2013;310(16):1666. doi:10.1001/jama.2013.281116.

Lab Reports | 
Tracy Hampton, PhD
JAMA. 2013;309(5):431. doi:10.1001/jama.2013.267.

Health Agencies Update | 
Bridget M. Kuehn, MSJ
JAMA. 2012;308(24):2557. doi:10.1001/jama.2012.156146.

Viewpoint | 
Thomas J. Moore, AB; Curt D. Furberg, MD, PhD
JAMA. 2012;308(9):869-870. doi:10.1001/jama.2012.9658.

Editorial | 
Tobias Derfuss, MD; Ludwig Kappos, MD
JAMA. 2012;308(3):290-291. doi:10.1001/jama.2012.8327.

Medical News and Perspectives | 
Bridget M. Kuehn
JAMA. 2012;307(24):2575-2576. doi:10.1001/jama.2012.6399.

Health Agencies Update | 
Bridget M. Kuehn
JAMA. 2012;307(24):2578. doi:10.1001/jama.2012.7064.

Health Agencies Update | 
Bridget M. Kuehn
JAMA. 2011;306(12):1315. doi:10.1001/jama.2011.1379.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Subscribe to the journal
From The JAMA Network
JAMA Neurology
Editorial  | 
Mycophenolate Mofetil to Treat Neuromyelitis Optica:  Is It Time for a Randomized Trial?
Bruce Cree, MD, PhD, MAS
JAMA Neurology
Original Investigation  | 
Mycophenolate Mofetil in the Treatment of Neuromyelitis Optica Spectrum Disorder
So-Young Huh, MD; Su-Hyun Kim, MD; Jae-Won Hyun, MD; et al.
JAMA Neurology
Case Report/Case Series  | 
Seroprevalence of Aquaporin-4–IgG in a Northern California Population Representative Cohort of Multiple Sclerosis
Sean J. Pittock, MD; Vanda A. Lennon, MD, PhD; Nandini Bakshi, MD; et al.
JAMA Neurology
Original Investigation  | 
The Clinical Meaning of Walking Speed as Measured by the Timed 25-Foot Walk in Patients With Multiple Sclerosis
Jeffrey A. Cohen, MD; Arun V. Krishnan, PhD; Andrew D. Goodman, MD; et al.